{
    "name": "benzocaine",
    "comment": "OTC",
    "other_names": [
        "EjectDelay"
    ],
    "classes": [
        "Anesthetics",
        "Oropharyngeal",
        "Anesthetics",
        "Topical",
        "Local Anesthetics",
        "Esters"
    ],
    "source": "https://reference.medscape.com/drug/benzocaine-343361",
    "pregnancy": {
        "common": [
            "Pregnancy Category: C",
            "Lactation: excretion in milk unknown; use with caution"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: excretion in milk unknown; use with caution"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to benzocaine or other ester-type local anesthetics",
                "Secondary bacterial infection of treated area"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Not for use in open wounds, for prolonged time and/or on large portions of the body; avoid contact with eyes",
                "Some dosage forms may contain benzyl alcohol; large amounts of benzyl alcohol associated with potentially fatal toxicity in neonates (gasping syndrome)",
                "Some dosage forms contain propylene glycol; large amounts are potentially toxic as they are associated with lactic acidosis, hyperosmolality, seizures and respiratory depression",
                "Rectal dosage form is for external use only; not for inserting into rectum using fingers or any mechanical device",
                "Irregular heartbeats, respiratory depression, seizures, and death reported in patients who applied topical anesthetics, without supervision of a trained professional, in large amounts or large areas of the skin, used wraps/dressing to cover skin, or left products on for prolonged periods of time"
            ],
            "specific": [
                {
                    "type": "Methemoglobinemia",
                    "description": [
                        "Methemoglobinemia reported following topical use, especially when high concentrations (14-20%) of spray formulations applied to mouth or mucous membranes; suspected cases should be confirmed by co-oximetry, as it yields accurate measures of methemoglobin levels",
                        "Not for use for teething or mouth pain in infants and children <2 years due to risk of methemoglobinemia",
                        "Use caution in patients with heart disease, hemoglobin or enzyme abnormalities, inflamed or damaged mucosa, or respiratory problems, including asthma, bronchitis, and emphysema in smokers; patients at risk should consider alternatives to benzocaine sprays"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Burning",
            "percent": null
        },
        {
            "name": "Contact dermatitis",
            "percent": null
        },
        {
            "name": "Edema",
            "percent": null
        },
        {
            "name": "Pruritus",
            "percent": null
        },
        {
            "name": "Erythema",
            "percent": null
        },
        {
            "name": "Rash",
            "percent": null
        },
        {
            "name": "Stinging tenderness",
            "percent": null
        },
        {
            "name": "Urticaria",
            "percent": null
        },
        {
            "name": "Methemoglobenemia",
            "percent": null
        }
    ]
}